Kendra Adams C4 Therapeutics, Inc. (CCCC) insider trading activity

Kendra Adams is Chief Financial Officer of C4 Therapeutics, Inc.. Currently has a direct ownership of 162,342 shares of CCCC, which is worth approximately $399,361. The most recent transaction as insider was on Sep 18, 2025, when has been sold 2,775 shares (Common Stock) at a price of $3.32 per share, resulting in proceeds of $9,213. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 162K

1.68% 3M change

98.48% 12M change

Total Value Held $399,361

Kendra Adams Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Sep 18 2025	SELL Payment of exercise price or tax liability	$9,213 $3.32 p/Share	2,775 Reduced 1.68%	162,342 Common Stock
Sep 18 2025	BUY Exercise of conversion of derivative security	-	6,250 Added 3.65%	165,117 Common Stock
Feb 14 2025	SELL Payment of exercise price or tax liability	$14,497 $3.18 p/Share	4,559 Reduced 2.69%	165,117 Common Stock
Feb 14 2025	BUY Grant, award, or other acquisition	-	87,100 Added 33.92%	169,676 Common Stock
Feb 13 2025	SELL Payment of exercise price or tax liability	$5,961 $3.2 p/Share	1,863 Reduced 2.21%	82,576 Common Stock
Nov 07 2024	SELL Payment of exercise price or tax liability	$6,656 $6.04 p/Share	1,102 Reduced 1.29%	84,439 Common Stock
Nov 07 2024	BUY Exercise of conversion of derivative security	-	3,750 Added 4.2%	85,541 Common Stock
Sep 18 2024	SELL Payment of exercise price or tax liability	$11,720 $6.38 p/Share	1,837 Reduced 2.2%	81,791 Common Stock
Sep 16 2024	SELL Payment of exercise price or tax liability	$4,203 $6.36 p/Share	661 Reduced 0.78%	83,628 Common Stock
Sep 16 2024	BUY Exercise of conversion of derivative security	-	2,250 Added 2.6%	84,289 Common Stock
Feb 14 2024	BUY Grant, award, or other acquisition	-	36,700 Added 30.91%	82,039 Common Stock
Feb 13 2024	SELL Payment of exercise price or tax liability	$8,495 $6.53 p/Share	1,301 Reduced 2.79%	45,339 Common Stock
Sep 18 2023	BUY Grant, award, or other acquisition	-	25,000 Added 34.9%	46,640 Common Stock

Kendra Adams

Chief Financial Officer

Watertown, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CCCC shares.

Notify only if

Value

Insider Trading

Get notified when an C4 Therapeutics, Inc. insider buys or sells CCCC shares.

Notify only if

Operation

Value

Type

News

Receive news related to C4 Therapeutics, Inc.

Track Activities on CCCC

Account